T1	intervention 0 11	Pamidronate
T2	condition 33 63	chemotherapy-induced bone loss
T4	control 561 568	placebo
T5	total-participants 572 574	40
T6	eligibility 575 629	premenopausal women with newly diagnosed breast cancer
T9	outcome 943 962	at the lumbar spine
T11	outcome 1009 1028	at the lumbar spine
T12	outcome 1038 1054	at the total hip
T7	outcome 866 900	percent change in BMD at 12 months
T10	outcome 1095 1133	Biochemical markers of bone remodeling
